Market Access Views & Analysis

Views & Analysis

Market Access

Is it time to rethink electronic prescribing in the US?

It is a fact of life that most – if not all – patients will require some form of prescription medication during their lifetime.

Market Access

Combination pricing: access to the future of oncology treatm...

Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world.

Market Access

Orphan drugs' financial success raises questions

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any.

Market Access

Closing the digital expectation gap in pharma

Jan Deman is Takeda’s head of digital customer experience for Europe and Canada. But he’d prefer not to refer to what he does as “innovation”.

Market Access

How do we make patient centricity a reality?

For years, the subject of fostering direct connections with patients has been highlighted by notable figures across the healthcare and life sciences industries as a key feature to be explor

Oncology

At ESMO, three studies show promise of antibody-drug conjuga...

The American Society of Clinical Oncology, or ASCO, conference is just around the corner, but one subgroup of cancer researchers just had their own gathering, as breast cancer researchers c

Is it time to rethink electronic prescribing in the US?

Combination pricing: access to the future of oncology treatm...

Orphan drugs' financial success raises questions

Closing the digital expectation gap in pharma

How do we make patient centricity a reality?

At ESMO, three studies show promise of antibody-drug conjuga...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Views & Analysis

Editor's Picks